Illumina, Inc. (NASDAQ:ILMN) Q4 2025 Earnings Call Transcript February 5, 2026 Illumina, Inc. beats earnings expectations.
Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Q4 2025 Earnings Call Transcript February 5, 2026 Adaptive Biotechnologies ...
Adaptive Biotechnologies Corporation ("Adaptive Biotechnologies") (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics ...
Q4 2025 earnings call recap: clonoSEQ MRD growth, 2026 revenue guidance, margins, cash burn and risks—read now.
Extracellular vesicles and particles are central to how cells communicate, especially in cancer, where they help shape metastasis and treatment resistance. However, most existing methods analyze ...
Although bioreactor scale-up often involves matching key engineering parameters, a biology-first approach should dictate the process.
VOWST sale boosts runway to Q2 2026; SER-155 Phase 2 is key after strong Phase 1b. Click here to read my most recent analysis of MCRB stock.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results